RECENT RELEASE: Examining Next Steps For Corporate Responsibility Programs In India
In this post in the Results for Development Institute’s “Center for Global Health R&D Policy Assessment” blog, Aarthi Rao, a program officer at the institute, examines whether corporate social responsibility (CSR) programs within Indian pharmaceutical companies can help fight neglected diseases. “Corporate giving amongst Indian pharmaceutical firms is still in its infancy and will likely evolve in the coming years as the industry continues to grow,” the she writes, adding, “As the breadth of social initiatives increases, it will be interesting to watch whether the social arms of firms will join their business counterparts in increasing the availability of neglected disease technologies” (7/23).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.